人类疾病中的精确基因组编辑:机制,策略和应用
Yanjiang Zheng1, Yifei Li1, Kaiyu Zhou1
1Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Signal transduction and targeted therapy
|February 26, 2024
概括
精确的基因组编辑技术已经显著发展,为DNA修饰和基因治疗提供了强大的工具. 尽管存在效率和交付等挑战,但持续的进步有望为遗传疾病提供革命性的治疗方法.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 精确的基因组编辑已经发展了70多年,从早期的DNA发现到复杂的体内应用.
- 这些工具正在彻底改变生命科学,并为新型遗传疾病治疗提供了希望.
- 目前的局限性包括适度的效率,交付障碍和非目标效应.
研究的目的:
- 审查精确基因组编辑的历史,平台,交付系统和应用.
- 突出标志性事件和基因组编辑策略的当前状态.
- 讨论该领域未来的进展.
主要方法:
- 精确基因组编辑里程碑的历史审查.
- 描述当前的基因组编辑策略及其精度.
- 介绍DNA,RNA和Ribonucleoprotein (RNP) 的传递系统.
主要成果:
- 基因组编辑为人类基因组修改提供了前所未有的精度和多功能性.
- 用于部署基因组编辑组件的各种交付系统.
- 应用范围包括基因标记,变异查,疾病建模和基因治疗.
结论:
- 精确基因组编辑是一个快速发展的领域,在研究和医学中具有广泛的应用.
- 持续开发旨在克服当前的限制,并扩大治疗潜力.
- 预计未来的进展将进一步增强基因疗法和疾病建模能力.
相关概念视频
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
What is Genetic Engineering?
74.1K
Overview
74.1K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


